Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 266

1.

Chronic Inflammatory Response Syndrome and the Lyme Patient.

Heyman A.

Altern Ther Health Med. 2018 Jun;24(S1):20-21.

PMID:
30982011
2.

Patient Perceptions of Sitting Versus Standing for Nurse Leader Rounding.

Pattison KH, Heyman A, Barlow J, Barrow K.

J Nurs Care Qual. 2017 Jan/Mar;32(1):1-5. No abstract available.

PMID:
27479517
3.

Patients' Perceptions of Bedside Handoff: Further Evidence to Support a Culture of Always.

Ford Y, Heyman A.

J Nurs Care Qual. 2017 Jan/Mar;32(1):15-24.

PMID:
27270846
4.

Patients' perceptions of bedside handoff: the need for a culture of always.

Ford Y, Heyman A, Chapman YL.

J Nurs Care Qual. 2014 Oct-Dec;29(4):371-8. doi: 10.1097/NCQ.0000000000000056.

PMID:
24487695
5.

Single-molecule DNA detection using a novel SP1 protein nanopore.

Wang HY, Li Y, Qin LX, Heyman A, Shoseyov O, Willner I, Long YT, Tian H.

Chem Commun (Camb). 2013 Feb 28;49(17):1741-3. doi: 10.1039/c3cc38939a.

PMID:
23340583
6.

Clues for biomimetics from natural composite materials.

Lapidot S, Meirovitch S, Sharon S, Heyman A, Kaplan DL, Shoseyov O.

Nanomedicine (Lond). 2012 Sep;7(9):1409-23. Review.

7.

Electrodeposition of single-metal nanoparticles on stable protein 1 membranes: application of plasmonic sensing by single nanoparticles.

Qin LX, Li Y, Li DW, Jing C, Chen BQ, Ma W, Heyman A, Shoseyov O, Willner I, Tian H, Long YT.

Angew Chem Int Ed Engl. 2012 Jan 2;51(1):140-4. doi: 10.1002/anie.201106482. Epub 2011 Nov 21. No abstract available.

PMID:
22105926
8.

Wiring of redox enzymes on three dimensional self-assembled molecular scaffold.

Frasconi M, Heyman A, Medalsy I, Porath D, Mazzei F, Shoseyov O.

Langmuir. 2011 Oct 18;27(20):12606-13. doi: 10.1021/la2020435. Epub 2011 Sep 22.

PMID:
21895003
9.

Formation of hydrophilic nanochannels in the membrane of living cells by the ringlike stable protein-SP1.

Khoutorsky A, Heyman A, Shoseyov O, Spira ME.

Nano Lett. 2011 Jul 13;11(7):2901-4. doi: 10.1021/nl201368w. Epub 2011 Jun 9.

PMID:
21651305
10.

Enhanced cellulose degradation by nano-complexed enzymes: Synergism between a scaffold-linked exoglucanase and a free endoglucanase.

Moraïs S, Heyman A, Barak Y, Caspi J, Wilson DB, Lamed R, Shoseyov O, Bayer EA.

J Biotechnol. 2010 Jun;147(3-4):205-11. doi: 10.1016/j.jbiotec.2010.04.012. Epub 2010 May 7.

PMID:
20438772
11.

Logic implementations using a single nanoparticle-protein hybrid.

Medalsy I, Klein M, Heyman A, Shoseyov O, Remacle F, Levine RD, Porath D.

Nat Nanotechnol. 2010 Jun;5(6):451-7. doi: 10.1038/nnano.2010.62. Epub 2010 Apr 18.

PMID:
20400968
12.

[The question bigger than the sum of legal and medical aspects].

Heyman A.

Lakartidningen. 2009 Sep 23-29;106(39):2475. Swedish. No abstract available.

PMID:
19856491
13.

Protein scaffold engineering towards tunable surface attachment.

Heyman A, Medalsy I, Bet Or O, Dgany O, Gottlieb M, Porath D, Shoseyov O.

Angew Chem Int Ed Engl. 2009;48(49):9290-4. doi: 10.1002/anie.200903075. No abstract available.

PMID:
19774580
14.

Float and compress: honeycomb-like array of a highly stable protein scaffold.

Heyman A, Medalsy I, Dgany O, Porath D, Markovich G, Shoseyov O.

Langmuir. 2009 May 5;25(9):5226-9. doi: 10.1021/la804132z.

PMID:
19397358
15.

Securing endotracheal tubes.

Heyman A.

Neonatal Netw. 2009 Mar-Apr;28(2):124. No abstract available.

PMID:
19332409
16.

Home or nursing home: does place of residence affect longevity in patients with Alzheimer's disease? The experience of CERAD patients.

Peterson BL, Fillenbaum GG, Pieper CF, Heyman A.

Public Health Nurs. 2008 Sep-Oct;25(5):490-7. doi: 10.1111/j.1525-1446.2008.00733.x.

PMID:
18816366
17.

Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC, Tariot PN, Silverman JM, Clark CM, Welsh-Bohmer KA, Heyman A.

Alzheimers Dement. 2008 Mar;4(2):96-109. doi: 10.1016/j.jalz.2007.08.005.

18.

Multiple display of catalytic modules on a protein scaffold: nano-fabrication of enzyme particles.

Heyman A, Barak Y, Caspi J, Wilson DB, Altman A, Bayer EA, Shoseyov O.

J Biotechnol. 2007 Sep 30;131(4):433-9. Epub 2007 Jul 26.

PMID:
17826857
19.

SP1 as a novel scaffold building block for self-assembly nanofabrication of submicron enzymatic structures.

Heyman A, Levy I, Altman A, Shoseyov O.

Nano Lett. 2007 Jun;7(6):1575-9. Epub 2007 May 26.

PMID:
17530810
20.

Performance on the CERAD neuropsychology battery of two samples of Japanese-American elders: norms for persons with and without dementia.

Fillenbaum GG, McCurry SM, Kuchibhatla M, Masaki KH, Borenstein AR, Foley DJ, Heyman A, Larson EB, White L.

J Int Neuropsychol Soc. 2005 Mar;11(2):192-201.

PMID:
15966108
21.

Keeping warm and staying well: findings from the qualitative arm of the Warm Homes Project.

Harrington BE, Heyman B, Merleau-Ponty N, Stockton H, Ritchie N, Heyman A.

Health Soc Care Community. 2005 May;13(3):259-67.

PMID:
15819747
22.

Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures.

Takao M, Ghetti B, Murrell JR, Unverzagt FW, Giaccone G, Tagliavini F, Bugiani O, Piccardo P, Hulette CM, Crain BJ, Farlow MR, Heyman A.

J Neuropathol Exp Neurol. 2001 Dec;60(12):1137-52.

PMID:
11764087
23.

Use and cost of outpatient visits of AD patients: CERAD XXII.

Fillenbaum G, Heyman A, Peterson BL, Pieper CF, Weiman AL.

Neurology. 2001 Jun 26;56(12):1706-11.

PMID:
11425938
24.

In-home assessment of dementia by nurses: experience using the CERAD evaluations. Consortium to Establish a Registry for Alzheimer's Disease.

Trapp-Moen B, Tyrey M, Cook G, Heyman A, Fillenbaum GG.

Gerontologist. 2001 Jun;41(3):406-9.

PMID:
11405439
25.

Performance of elderly African American and White community residents on the CERAD Neuropsychological Battery.

Fillenbaum GG, Heyman A, Huber MS, Ganguli M, Unverzagt FW.

J Int Neuropsychol Soc. 2001 May;7(4):502-9.

PMID:
11396552
26.

Use and cost of hospitalization of patients with AD by stage and living arrangement: CERAD XXI.

Fillenbaum G, Heyman A, Peterson BL, Pieper CF, Weiman AL.

Neurology. 2001 Jan 23;56(2):201-6.

PMID:
11160956
27.

Frequency and duration of hospitalization of patients with AD based on Medicare data: CERAD XX.

Fillenbaum G, Heyman A, Peterson B, Pieper C, Weiman AL.

Neurology. 2000 Feb 8;54(3):740-3. Erratum in: Neurology 2000 Apr 25;54(8):1712.

PMID:
10680815
28.
29.

Comparison of Lewy body variant of Alzheimer's disease with pure Alzheimer's disease: Consortium to Establish a Registry for Alzheimer's Disease, Part XIX.

Heyman A, Fillenbaum GG, Gearing M, Mirra SS, Welsh-Bohmer KA, Peterson B, Pieper C.

Neurology. 1999 Jun 10;52(9):1839-44.

PMID:
10371532
31.

Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease.

Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF.

Neurology. 1998 Jul;51(1):159-62. Erratum in: Neurology 1998 Dec;51(6):1809.

PMID:
9674796
32.
33.

The prevalence and 3-year incidence of dementia in older Black and White community residents.

Fillenbaum GG, Heyman A, Huber MS, Woodbury MA, Leiss J, Schmader KE, Bohannon A, Trapp-Moen B.

J Clin Epidemiol. 1998 Jul;51(7):587-95.

PMID:
9674666
34.

Overview: clinical sites, case material, and special studies.

Heyman A, Fillenbaum GG.

Neurology. 1997 Sep;49(3 Suppl 3):S2-6. No abstract available.

PMID:
9310505
35.

Consortium to establish a registry for Alzheimer's disease: development, database structure, and selected findings.

Fillenbaum GG, Beekly D, Edland SD, Hughes JP, Heyman A, van Belle G.

Top Health Inf Manage. 1997 Aug;18(1):47-58.

PMID:
10173753
36.

The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.

Clark CM, Ewbank D, Lerner A, Doody R, Henderson VW, Panisset M, Morris JC, Fillenbaum GG, Heyman A.

Neurology. 1997 Jul;49(1):70-5.

PMID:
9222172
37.

Predictors of time to institutionalization of patients with Alzheimer's disease: the CERAD experience, part XVII.

Heyman A, Peterson B, Fillenbaum G, Pieper C.

Neurology. 1997 May;48(5):1304-9.

PMID:
9153462
38.

Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases.

Hulette C, Nochlin D, McKeel D, Morris JC, Mirra SS, Sumi SM, Heyman A.

Neurology. 1997 Mar;48(3):668-72.

PMID:
9065545
39.

Measurement choices in multi-site studies of outcomes in dementia.

Smyth KA, Ferris SH, Fox P, Heyman A, Holmes D, Morris JN, Phillips CD, Schulz R, Teresi J, Whitehouse PJ.

Alzheimer Dis Assoc Disord. 1997;11 Suppl 6:30-44.

PMID:
9437446
40.

Re: The glidewire technique for overcoming urethral obstruction.

Heyman AM.

J Urol. 1997 Jan;157(1):267-8. No abstract available.

PMID:
8976271
41.

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A.

Neurology. 1996 Jun;46(6):1592-6.

PMID:
8649554
43.

Neuropsychological test performance in African-American and white patients with Alzheimer's disease.

Welsh KA, Fillenbaum G, Wilkinson W, Heyman A, Mohs RC, Stern Y, Harrell L, Edland SD, Beekly D.

Neurology. 1995 Dec;45(12):2207-11.

PMID:
8848195
44.
45.

Prophylactic nasogastric tube decompression: is its use justified?

Schwartz CI, Heyman AS, Rao AC.

South Med J. 1995 Aug;88(8):825-30.

PMID:
7631207
46.
47.

The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease.

Davis PC, Gearing M, Gray L, Mirra SS, Morris JC, Edland SD, Lin T, Heyman A.

Neurology. 1995 Jan;45(1):178-9.

PMID:
7824112
49.

Translation of clinical and neuropsychological instruments into French: the CERAD experience.

Demers P, Robillard A, Laflèche G, Nash F, Heyman A, Fillenbaum G.

Age Ageing. 1994 Nov;23(6):449-51.

PMID:
9231936
50.

CERAD part VII: accuracy of reporting dementia on death certificates of patients with Alzheimer's disease.

Raiford K, Anton-Johnson S, Haycox Z, Nolan K, Schaffer A, Caimano C, Fillenbaum G, Heyman A.

Neurology. 1994 Nov;44(11):2208-9. No abstract available.

PMID:
7969991

Supplemental Content

Loading ...
Support Center